Z. John Zhong

30 total papers · 7.2k total citations
22 papers, 5.2k citations indexed

About

Z. John Zhong is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Z. John Zhong has authored 22 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 15 papers in Immunology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Z. John Zhong's work include Systemic Lupus Erythematosus Research (18 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and T-cell and B-cell Immunology (10 papers). Z. John Zhong is often cited by papers focused on Systemic Lupus Erythematosus Research (18 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and T-cell and B-cell Immunology (10 papers). Z. John Zhong collaborates with scholars based in United States, Spain and United Kingdom. Z. John Zhong's co-authors include William W. Freimuth, Michelle Petri, Joan T. Merrill, Richard Furie, William Stohl, Ellen M. Ginzler, Winn Chatham, Daniel J. Wallace, Ricard Cervera and Ronald van Vollenhoven and has published in prestigious journals such as The Lancet, Annals of the Rheumatic Diseases and Lupus.

In The Last Decade

Z. John Zhong

20 papers receiving 5.0k citations

Hit Papers

Efficacy and safety of be... 2011 2026 2016 2021 2011 2011 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
    2011 1.4k citations Sandra Navarra, Renato Guzmán et al. The Lancet profile →
  2. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
    2011 1.1k citations Richard Furie, Michelle Petri et al. Arthritis & Rheumatism profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Z. John Zhong 4.4k 3.4k 2.5k 514 388 22 5.2k
William W. Freimuth 4.8k 1.1× 4.0k 1.2× 2.9k 1.1× 555 1.1× 480 1.2× 54 7.0k
Winn Chatham 3.1k 0.7× 2.7k 0.8× 1.7k 0.7× 448 0.9× 359 0.9× 44 4.7k
Kevin Latinis 2.1k 0.5× 1.9k 0.6× 1.3k 0.5× 413 0.8× 432 1.1× 21 4.0k
Paul Brunetta 2.5k 0.6× 1.7k 0.5× 1.2k 0.5× 443 0.9× 333 0.9× 30 3.6k
Cheryl Yarboro 3.3k 0.7× 2.6k 0.7× 848 0.3× 503 1.0× 449 1.2× 51 5.3k
Lilia Pineda 2.3k 0.5× 1.8k 0.5× 1.1k 0.4× 287 0.6× 316 0.8× 17 2.9k
Holly M. Bastian 3.3k 0.8× 2.1k 0.6× 673 0.3× 567 1.1× 156 0.4× 41 4.0k
Jorge Sánchez‐Guerrero 5.3k 1.2× 3.0k 0.9× 1.7k 0.7× 991 1.9× 437 1.1× 87 7.0k
Tammy O. Utset 2.3k 0.5× 1.9k 0.6× 721 0.3× 360 0.7× 377 1.0× 43 3.2k
G. Dennis 2.1k 0.5× 1.9k 0.6× 899 0.4× 434 0.8× 253 0.7× 37 3.6k

Countries citing papers authored by Z. John Zhong

Since Specialization
Citations

This map shows the geographic impact of Z. John Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z. John Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z. John Zhong more than expected).

Fields of papers citing papers by Z. John Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Z. John Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z. John Zhong. The network helps show where Z. John Zhong may publish in the future.

Co-authorship network of co-authors of Z. John Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Z. John Zhong. A scholar is included among the top collaborators of Z. John Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Z. John Zhong. Z. John Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moira Glaccum Breakdown of academic impact, for papers by James A. Dale Breakdown of academic impact, for papers by Carol L. Fye Breakdown of academic impact, for papers by Markus Loeffler Breakdown of academic impact, for papers by Barbara A. Barres Breakdown of academic impact, for papers by Robert Muth Breakdown of academic impact, for papers by Terrence Xu Breakdown of academic impact, for papers by Jack X. Yu
Rankless by CCL
2026